Strides Pharma Science Limited (STAR) — Stock Analysis

Strides Pharma Science Limited (NSE: STAR), ISIN INE939A01011 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.

STAR last traded at ₹1074.00 (+1.32%), with a 52-week range of ₹769.60 to ₹1231.45 (as of 30 Jul 2026).

Shareholding as of Jun 2026: promoters 27.91%, FIIs 28.39%, DIIs 15.41%, mutual funds 8.73%.

EquiSense Score (ECS): 68/100.

Data sourced from NSE and BSE filings. Educational — not investment advice.